Jiangsu Cancer Hospital (Jiangsu Institute of Cancer Research, the Affiliated Cancer Hospital of Nanjing Medical University) is a grade A class-three cancer hospital, which was derived from Jiangsu Hospital founded in 1960.It is the instruction center for cancer prevention, therapy, research and education in Jiangsu Province. It has been listed in the "Annual National Best Oncology Reputation Ranking" compiled by Hospital Management Institute of Fudan University for 6 consecutive years. In 2015, Jiangsu Cancer Hospital made its first appearance in the Top 100 Best Hospitals in China.
Jiangsu Cancer Hospital is State Institution of Drug Clinical Trials, the first batch of National Standardized Training Base for Resident Physicians and Standardized Cancer Pain Treatment Demonstration Ward announced by the Ministry of Health, Guidance Hospital for Standardized Treatment of Malignant Tumors in Municipalities and Counties announced by the Ministry of Health, National Postdoctoral Research Workstation, Jiangsu Cancer Specialist Nurse Training Base and Director Unit of Jiangsu Cancer Prevention and Control Alliance. In addition, Jiangsu Anti-cancer Association, Jiangsu Cancer Prevention and Control Office, Jiangsu Clinical Laboratory Center and Chinese Journal of Cancer Surgery are all located in the hospital.
Jiangsu Cancer Hospital actively promotes the development of cancer prevention and treatment in Jiangsu Province. It has 1161 open beds with 1581 employees and 25 clinical and medical departments which include 2 state key state clinical specialty units, 4 Jiangsu clinical specialty units, 3 specialty (disease) clinical diagnosis and treatment centers and 3 provincial quality control centers.
Jiangsu Cancer Hospital insists on the strategy of developing the hospital through research and education. There are 7 fundamental research laboratories and 1 clinical cancer laboratory center. It has established 5 high-level academic research platforms with important influence in Jiangsu province, namely Jiangsu Cancer Biotherapy Center, Clinical Research Center for Precision Medicine and the first batch of clinical application pilot units for Clinical Application of Sequencing in China. Besides, it has won 2 first prizes of Jiangsu Science and Technology Progress Award and 1 second prize of National Science and Technology Progress Award. In 2017, Jiangsu Cancer Hospital achieved 12 projects funded by National Natural Science Foundation of China and has been listed in the reserve project for Improving the Ability of Diagnosis and Treatment of Difficult Diseases.
Adhering to the service principal of "Always do the right things for patients", Jiangsu Cancer Hospital is accelerating the pace of construction. As the key livelihood project, expansion project is about to start construction. In addition, Jiangsu Proton Heavy Ion Therapy Center is actively under construction. Jiangsu Cancer Hospital focuses on innovation and development, and strives to build the hospital into national first-class cancer prevention and control center.